Syndax Pharmaceuticals (NASDAQ:SNDX) Rating Increased to Sell at StockNews.com
Syndax Pharmaceuticals (NASDAQ:SNDX – Get Free Report) was upgraded by research analysts at StockNews.com to a “sell” rating in a research note issued to investors on Wednesday. SNDX has been the subject of several other reports. HC Wainwright reaffirmed a “buy” rating and issued a $51.00 price target on shares of Syndax Pharmaceuticals in a […]
Syndax Pharmaceuticals (NASDAQ:SNDX – Get Free Report) was upgraded by research analysts at StockNews.com to a “sell” rating in a research note issued to investors on Wednesday. SNDX has been the subject of several other reports. HC Wainwright reaffirmed a “buy” rating and issued a $51.00 price target on shares of Syndax Pharmaceuticals in a […]
